Johnson & Johnson Innovation plans to open a JLABS life science incubator in Shanghai’s Zhangjiang Hi-Tech Park, with space for 50 startup companies. The 47,000 square foot facility, the first JLABS site located outside North America, will be operational in Q2 2019. J&J said JLABS @ Shanghai will seek innovative companies from the entire healthcare spectrum, including pharmaceuticals, medical devices and consumer products. JLABS says its “no strings attached” model offers resident innovators a capital efficient and flexible platform for developing products.
Source: China Biotoday
